AnalystsLi WatsekLi Watsek's Stock Forecasts
AnalystsLi Watsek
Sectors:
Industries:
Analyst Ranking
Bottom 8%
#4226 out of 4565 analysts
Average Return
-6.74%
Win Rate
45%20 out of 44
Risk vs Reward
Poor
Good
Li Watsek's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alx Oncology Holdings IncALXO | +164.42% | $6.38 | $16.87 | 2023-10-03 - 2024-04-25 | Strong Buy |
Ascendis Pharma AASND | +95.73% | $69.96 | $136.93 | 2023-04-27 - 2024-04-25 | Strong Buy |
Kura Oncology IncKURA | +90.76% | $9.96 | $19.00 | 2023-09-06 - 2024-04-25 | Strong Buy |
Kura Oncology IncKURA | +72.57% | $11.01 | $19.00 | 2023-07-20 - 2024-04-25 | Strong Buy |
Ascendis Pharma AASND | +55.67% | $87.96 | $136.93 | 2023-05-31 - 2024-04-25 | Strong Buy |
Li Watsek Analyst Color
Get additional color on Li Watsek's coverage of popular stocks
Li Watsek's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ascendis Pharma AASND | 8 | Strong Buy | $173.00 | +26.34% | Reiterates | 8 days ago |
Sellas Life Sciences Group IncSLS | 3 | Strong Buy | $3.00 | +97.37% | Reiterates | 5 months ago |
Arcus Biosciences IncRCUS | 1 | Strong Buy | $36.00 | +144.40% | Maintains | 6 months ago |
Bicycle Therapeutics PLCBCYC | 4 | Strong Buy | $65.00 | +188.63% | Reiterates | 6 months ago |
Alx Oncology Holdings IncALXO | 1 | Strong Buy | $23.00 | +36.34% | Maintains | 7 months ago |
Affimed NvAFMD | 4 | Strong Buy | $70.00 | +1,334.43% | Reiterates | 7 months ago |
Vincerx Pharma IncVINC | 3 | Strong Buy | $5.00 | +457.41% | Reiterates | 8 months ago |
Portage Biotech IncPRTG | 3 | Strong Buy | $11.00 | +4,541.35% | Reiterates | 8 months ago |
Oncternal Therapeutics IncONCT | 3 | Hold | $26.00 | +215.15% | Reiterates | 8 months ago |
Kura Oncology IncKURA | 4 | Strong Buy | $30.00 | +57.89% | Reiterates | 8 months ago |
Fate Therapeutics IncFATE | 3 | Hold | $5.00 | +29.20% | Reiterates | 8 months ago |
Corvus Pharmaceuticals IncCRVS | 4 | Strong Buy | $4.00 | +170.27% | Reiterates | 8 months ago |
Arvinas IncARVN | 2 | Strong Buy | $70.00 | +121.52% | Reiterates | 8 months ago |
Aptose Biosciences IncAPTO | 2 | Strong Buy | $38.00 | +3,175.86% | Reiterates | 8 months ago |
Nkarta IncNKTX | 1 | Strong Buy | $38.00 | N/A | Maintains | 2 years ago |
Global Blood Therapeutics IncGBT | 2 | Hold | $68.50 | N/A | Downgrades | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.